Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis

April 17, 2026 updated by: Deepak Kumar, Boston University Charles River Campus

Effects of Music-Based Rhythmic Auditory Stimulation During Walking on Nociceptive Signaling and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis

The purpose of this research study is to compare muscle activation, changes in pain sensitivity, and brain function, between different walking conditions, including walking to music, walking to metronome, and walking without music or metronome.

Study Overview

Detailed Description

Participants with knee osteoarthritis (OA) will complete a single study visit which will include three walking tasks, each being 25 minutes in duration. The walking tasks will include walking without music or metronome, walking to metronome, and walking with music. Participants muscle activity, brain activity, and movements will be recorded during these tasks. Participant's pressure pain threshold will be recorded at the beginning and after each task.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Deepak Kumar, PT, PhD
  • Phone Number: 617-358-3037
  • Email: kumard@bu.edu

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Have activity related pain
  • Experience morning knee stiffness ≤ 30 minutes
  • Knee pain on most days for 3 months or more
  • Able to walk at least 20 minutes with assistance
  • Average overall knee pain severity of ≥= 4 on a 11-point numeric rating scale during previous week
  • BMI ≤ 40
  • Able to communicate using English at a level to understand the study procedures and informed consent

Exclusion Criteria:

  • Contraindications to exercise
  • Joint replacement in either hip, knee, or ankle
  • History of other disease that may involve the index joint including inflammatory joint disease such as rheumatoid arthritis, seronegative spondyloarthropathy (eg, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease related arthropathy), crystalline disease (eg, gout or pseudogout), lupus erythematosus, knee joint infections, Paget's disease affecting the knee, or knee joint tumors.
  • Previous knee osteotomy in either knee
  • Other health conditions that impact motor functioning or prevent participation (e.g., stroke, Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, diabetic neuropathy, etc.)
  • Corticosteroid or hyaluronic acid injections in either knee in the previous 3 months
  • Pregnancy (self-report)
  • Suspected or known drugs or alcohol abuse
  • Mini-mental State Examination (MMSE) score < 24
  • Hearing impairments
  • Pain in lower back or legs that is greater than knee pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rhythmic auditory stimulation during walking
All participants will be exposed to different walking conditions including music, metronome, and no music or metronome
Walking to rhythmic Auditory Stimulation with music
walking to rhythmic Auditory Stimulation with metronome
Walking to no music or metronome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise-Induced Hypoalgesia (EIH)
Time Frame: Baseline
Change in pressure pain threshold (PPT) from baseline to after each walking task
Baseline
medial quadriceps - medial hamstrings muscle coactivation
Time Frame: Baseline
Medial quadriceps-medial hamstrings muscle co-activation in each walking task will be assessed using surface electromyography
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medial quadriceps- medial gastrocnemius muscle coactivation
Time Frame: Baseline
Medial quadriceps-medial gastrocnemius muscle co-activation in each walking task will be assessed using surface electromyography
Baseline
lateral quadriceps- lateral hamstrings muscle coactivation
Time Frame: Baseline
Lateral quadriceps-lateral hamstrings muscle co-activation in each walking task will be assessed using surface electromyography
Baseline
lateral quadriceps - lateral gastrocnemius muscle coactivation
Time Frame: Baseline
Lateral quadriceps-lateral gastrocnemoius muscle co-activation in each walking task will be assessed using surface electromyography
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Auditory-motor synchronization
Time Frame: Baseline
difference between actual cadence and target cadence in each walking ask (except walking to no music or metronome)
Baseline
physical activity enjoyment
Time Frame: Baseline
Modified Physical Activity Enjoyment Scale (PACES) score after each walking task. Range is 7-49 with higher scores indicating greater enjoyment.
Baseline
Prefrontal cortex activation
Time Frame: Baseline
Prefrontal cortex (PFC) brain activation during each walking task will be assessed using functional near-infrared spectroscopy (fNIRS)
Baseline
Supplementary Motor Area activation
Time Frame: Baseline
Supplementary Motor Area (SMA) brain activation during each walking task will be assessed using functional near-infrared spectroscopy (fNIRS)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Deepak Kumar, PT, PhD, Boston University Charles River Campus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

April 6, 2026

First Submitted That Met QC Criteria

April 12, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Requests will be considered on an individual basis

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Rhythmic Auditory Stimulation with music

Subscribe